550 related articles for article (PubMed ID: 3053124)
61. [Morphology of the gastric mucosa in patients with duodenal ulcer treated with bismuth-containing drugs].
Mach T
Folia Med Cracov; 1995; 36(1-4):53-75. PubMed ID: 8834668
[TBL] [Abstract][Full Text] [Related]
62. [Assessment of the efficacy of de-nol and bismuth subnitrate treatment of patients with associated peptic ulcer and pyloric Helicobacter infection (experimental and clinical studies)].
Il'chenko AA; Zurabishvili NG; Zhukhovitskiĭ BG; Gorodinskaia VS
Ter Arkh; 1991; 63(2):21-6. PubMed ID: 2048016
[TBL] [Abstract][Full Text] [Related]
63. [Drug therapy of peptic ulcer in the elderly].
Koop H
Z Gerontol; 1992; 25(5):304-8. PubMed ID: 1359717
[TBL] [Abstract][Full Text] [Related]
64. Influence of colloidal bismuth subcitrate on enzyme secretion from isolated rat pancreatic acinar cells.
Kemmer TP; Malfertheiner P; Bode G; Ditschuneit H
Res Exp Med (Berl); 1992; 192(6):415-22. PubMed ID: 1282729
[TBL] [Abstract][Full Text] [Related]
65. Update in treatment of peptic ulcer disease.
Schubert TT
Mo Med; 1984 Nov; 81(11):723-7. PubMed ID: 6095013
[No Abstract] [Full Text] [Related]
66. Drug therapy of peptic ulcer disease.
Peppercorn MA
Compr Ther; 1983 Nov; 9(11):47-52. PubMed ID: 6139199
[TBL] [Abstract][Full Text] [Related]
67. The medical management of peptic ulcer.
Shearman DJ; Hetzel D
Annu Rev Med; 1979; 30():61-79. PubMed ID: 45409
[No Abstract] [Full Text] [Related]
68. Colloidal bismuth subcitrate inhibits peptic degradation of gastric mucus and epidermal growth factor in vitro.
Slomiany BL; Nishikawa H; Bilski J; Slomiany A
Am J Gastroenterol; 1990 Apr; 85(4):390-3. PubMed ID: 2109526
[TBL] [Abstract][Full Text] [Related]
69. [Innovations in the treatment of gastroduodenal ulcers].
Bernier JJ
Presse Med; 1983 May; 12(21):1355-8. PubMed ID: 6304676
[TBL] [Abstract][Full Text] [Related]
70. Therapeutics used to alleviate peptic ulcers inhibit H. pylori receptor binding in vitro.
Huesca M; Gold B; Sherman P; Lewin P; Lingwood C
Zentralbl Bakteriol; 1993 Sep; 280(1-2):244-52. PubMed ID: 8280948
[TBL] [Abstract][Full Text] [Related]
71. Colloidal bismuth subcitrate causes sustained release of gastric mucosal prostaglandin E2.
Mertz-Nielsen A; Steenberg P; Neumark T; Bukhave K; Rask-Madsen J
Aliment Pharmacol Ther; 1991 Apr; 5(2):127-33. PubMed ID: 1888815
[TBL] [Abstract][Full Text] [Related]
72. Helicobacter pylori infection in childhood: results of management with ranitidine bismuth citrate plus amoxicillin and tinidazole.
Nijevitch AA; Farztdinov KM; Sataev VU; Khasanov RSh ; Katayev VA; Khusnutdinov SM; Akhunov ED; Kazykhanov NS
J Gastroenterol Hepatol; 2000 Nov; 15(11):1243-50. PubMed ID: 11129216
[TBL] [Abstract][Full Text] [Related]
73. Colloidal bismuth subcitrate and ranitidine in the short-term treatment of benign gastric ulcer. An endoscopically controlled trial.
Parente F; Lazzaroni M; Petrillo M; Bianchi Porro G
Scand J Gastroenterol Suppl; 1986; 122():42-5. PubMed ID: 3465027
[TBL] [Abstract][Full Text] [Related]
74. Healing of gastric body ulcer with gastroprotective versus antisecretory treatment.
Jablonská M
Dig Dis Sci; 1995 Sep; 40(9):2016-8. PubMed ID: 7555458
[TBL] [Abstract][Full Text] [Related]
75. The other option in peptic ulcer therapy.
Halter F
S Afr Med J; 1984 Jun; 65(25):996-1000. PubMed ID: 6374932
[TBL] [Abstract][Full Text] [Related]
76. [Influence of colloidal bismuth subcitrate, metronidazole, and amoxycillin on Helicobacter pylori and gastroduodenal ulcer healing].
Quintero M; Moderos I; Buesa F; Gonzalez Cansino R; Haedo W
G E N; 1995; 49(2):116-22. PubMed ID: 8566682
[TBL] [Abstract][Full Text] [Related]
77. Distribution of bismuth in the rat after oral dosing with ranitidine bismuth citrate and bismuth subcitrate.
Canena J; Reis J; Pinto AS; Santos AM; Leitão J; Pinheiro T; Quina MG
J Pharm Pharmacol; 1998 Mar; 50(3):279-83. PubMed ID: 9600719
[TBL] [Abstract][Full Text] [Related]
78. Protection against chemically-induced oxidative gastrointestinal tissue injury in rats by bismuth salts.
Bagchi D; Carryl OR; Tran MX; Bagchi M; Vuchetich PJ; Krohn RL; Ray SD; Mitra S; Stohs SJ
Dig Dis Sci; 1997 Sep; 42(9):1890-900. PubMed ID: 9331152
[TBL] [Abstract][Full Text] [Related]
79. Colloidal bismuth subcitrate and two different dosages of cimetidine in the treatment of resistant duodenal ulcer. Preliminary results.
Bianchi Porro G; Parente F; Lazzaroni M; Pace F
Scand J Gastroenterol Suppl; 1986; 122():39-41. PubMed ID: 2877490
[TBL] [Abstract][Full Text] [Related]
80. One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial.
van der Wouden EJ; Thijs JC; van Zwet AA; Kooy A; Kleibeuker JH
Am J Gastroenterol; 1998 Aug; 93(8):1228-31. PubMed ID: 9707042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
